Report: Prices drop for major medical implants

September 23, 2013 by Arezu Sarvestani

Hospitals in 2011 paid 34% less per device for drug-eluting stents than they paid in 2007, according to a new AdvaMed report which also found substantial price-cuts for 6 other categories of major medical implants.

Updated September 23, 2013, at 6:45 p.m. with comments from AdvaMed chairman David Dvorak.

Report: Prices drop for major medical implants

Hospitals in 2011 paid an average of 34% less for drug-eluting stents than they did in 2007, according to a new report. They also paid 27% less for bare metal stents and 26% less for both pacemakers and cardiac resynchronization therapy defibrillators.

The findings reinforce previous AdvaMed studies, which have found that medical device spending makes up a consistently small percentage of the U.S. healthcare budget and that average device prices have increased at a rate of about 1% per year since 2000.

Sign up to get our free newsletters delivered right to your inbox.

"What else in health care can you say is going down in terms of price?" AdvaMed president & CEO Stephen Ubl told Bloomberg. "At least in this part of health care, good old fashioned competition works well."

Comments